Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

18.6K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
18.6K
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

123
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
123
Protein Folding01:25

Protein Folding

9.4K
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in Interleukin-2 Engineering and Delivery Systems for Cancer Immunotherapy.

ACS applied bio materials·2026
Same author

A glucose-responsive dual-nanoparticle-hydrogel-based microneedle patch for co-delivery of insulin and exendin-4.

Biomaterials science·2026
Same author

Protein Post-Translational Modification-Inspired Regulation of Peptide Coacervation in Living Cells for Pro-Necroptotic Kinase Delivery.

Journal of the American Chemical Society·2026
Same author

Cancer nanomedicine for therapy: emerging strategies and expanding perspectives.

Cancer biology & medicine·2026
Same author

Tyr39 Phosphorylation of α-Synuclein Accelerates Heterotypic Aggregation and Drives Toxic Amplification.

Journal of the American Chemical Society·2026
Same author

Rigid and stable nitroxide spin label for high-resolution distance measurements on proteins by DEER experiments.

Magnetic resonance letters·2026

Related Experiment Video

Updated: Oct 2, 2025

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time
07:56

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time

Published on: May 30, 2021

3.3K

Tailoring a Nanochaperone to Regulate α-Synuclein Assembly.

Xiaohui Wu1, Feihe Ma2, Bin-Bin Pan3

  • 1Key Laboratory of Functional Polymer Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Institute of Polymer Chemistry and College of Chemistry, Nankai University, Tianjin, 300071, P. R. China.

Angewandte Chemie (International Ed. in English)
|March 1, 2022
PubMed
Summary

A novel nanochaperone, alphaS-nChap, effectively regulates alpha-synuclein assembly, preventing toxic protein aggregation implicated in Parkinson's disease and promoting its degradation.

Keywords:
Chaperone ProteinsNanochaperoneProtein FoldingSelf-Assemblyα-Synuclein Pathology

More Related Videos

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy
12:58

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy

Published on: September 12, 2019

9.9K
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

21.8K

Related Experiment Videos

Last Updated: Oct 2, 2025

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time
07:56

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time

Published on: May 30, 2021

3.3K
Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy
12:58

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy

Published on: September 12, 2019

9.9K
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

21.8K

Area of Science:

  • Biochemistry
  • Neuroscience
  • Nanotechnology

Background:

  • Protein misassembly into toxic species drives neurodegenerative diseases like Parkinson's and Alzheimer's.
  • Alpha-synuclein aggregation is a key pathological hallmark in Parkinson's disease.

Purpose of the Study:

  • To engineer a nanochaperone (alphaS-nChap) specifically designed to control alpha-synuclein's aberrant assembly.
  • To investigate the therapeutic potential of alphaS-nChap in preventing alpha-synuclein-related cellular pathology and neuronal apoptosis.

Main Methods:

  • In vitro characterization of alphaS-nChap's interaction with alpha-synuclein monomers and oligomers.
  • Cellular assays to evaluate alphaS-nChap's efficacy in preventing alpha-synuclein aggregation and protecting neurons.
  • Assessment of alphaS-nChap's role in directing alpha-synuclein oligomers for lysosomal degradation.

Main Results:

  • AlphaS-nChap specifically recognizes and binds to alpha-synuclein.
  • The nanochaperone effectively stabilizes monomeric alpha-synuclein, inhibits oligomerization, and captures existing oligomers, preventing fibril formation.
  • AlphaS-nChap demonstrated protective effects against alpha-synuclein pathology in cellular models and reduced neuronal apoptosis.

Conclusions:

  • Tailoring nanochaperones offers a promising strategy for managing protein misfolding diseases.
  • AlphaS-nChap shows significant therapeutic potential for Parkinson's disease by modulating alpha-synuclein aggregation and promoting its clearance.